Vol. 7 (03) pp. 549-553 DOI: 10.21474/IJAR01/8669

INCIDENTAL PROSTATE CANCER IN TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) SPECIMENS HAVING INTERMEDIATE SERUM PROSTATE-SPECIFIC ANTIGEN (PSA) LEVEL.

, , , , and
15 Downloads 112 Views
Crossref

Download Full Paper (PDF)

Abstract

Background: Prostate cancer is malignancy of elderly males. Latent prostate cancer are quite common after 60 years of age. It has been known that Serum prostate-specific antigen (PSA) level >10mg/ml are associated with prostate cancer. Aim: Present study was planned to determine the incidence of latent prostate cancer in patients undergoing Transurethral resection of the prostate (TURP) for Benign prostatic hyperplasia (BPH) and also histopathological outcome of patients having PSA level between 4 to 10ng/ml. Materials and methods: A total of 181 patients undergoing TURP for BPH were included in the study. Their age, PSA level, TURP, and histopathological outcome were analyzed. Result: Out of 181 patients undergoing TURP for BPH, 7 had prostate carcinoma and also had serum PSA level between 4-10ng/ml. Conclusion: Prostate cancer confined to prostate (stage 1) may be incidentally present in TURP patients with clinical diagnosis of BPH. So detailed histopathological examination and serum PSA level help in early diagnosis of stage 1 prostate cancer.

Keywords

Article Analytics

References

  1. Bostwick D, Cheng L, Chapter 9. Neoplasm of the prostate. In:Bostwick D, ed. Urologic surgical pathology. 2ndPortland: Mosby Elsevier: 2008:410-3.
  2. Ganesh B, Saoba SL, SaradeMN,Pinjari SV. Risk factor for prostate cancer: A hospital based case control study from Mumbai, India. Ind J Urol 2011; 27:345-50.
  3. I. Epstein,G.Paull,J.C. Eggleston. P.C. Walsh, ?Prognosis of untreated stage A1 prostate carcinoma: a study of 94 cases with extended follow-up,? Journal of Urology, 1986; 36(4): 837-39.
  4. Antunes AA, FreireGde C, Aiello D, CuryJ,Srougi M. Aanalysis of the risk factors for incidental carcinoma of the patients with benign prostatic hyperplasia, Clinics (Sao Paulo)2006;61:545-50.
  5. Di SilverioF,GentileV,DeMatteisA,MariottiG,GiuseppeV,Luigi PA, et al. Distribution of inflammation, premalignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia:a retrospective analysis.EurUrol 2003; 43:164-75.
  6. Berry SJ,CoffeyDS,Walah PC, Ewing LL,the development of human benign prostatic hyperplasia with age, 1984;132(4): 474-479.
  7. RoehrbornC,McConnell J, Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. In Walsh P, RetikA,VaughanE,Wein A, editors. Campbell,s Urology. 8th Philadelphia: Saundes: 2002:1297-1336.
  8. E. Zigeuner K, Lipsky, Riedler, M Auprich, L Schips, M Salfellner,et al, did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patents Urology;2003; 62:451-455.
  9. JonesJS,FollisHW,JohnsonJR.Probability of finding T1a and T1b (incidental) Prostate cancer during TURP has decreased in the PSA era.Prostate Cancer Prostatic Dis.2009; 12(1):57-60.
  10. Yoo C, Oh CY,KimSJ,Kim SI, Kim YS, Park JY.et al, ?Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative for benign prostatic hyperplasia: a Korean multi-center review ?Korean Journal of Urology, 2012; 53: 391-5.
  11. Tombal,L.deVisccher, J.P.Cosyns et al, ?Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13 year retrospective study of the incidence and natural history of T1a-T1b prostate cancer?, BJU International, 1999;84(9):1015-1020.

How to Cite This Article

Preeti Singh, Vijay Kumar, Abhishek Jain, Ganesh Singh, Amod Kumar Saroj and Veer Karuna. (2019); INCIDENTAL PROSTATE CANCER IN TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) SPECIMENS HAVING INTERMEDIATE SERUM PROSTATE-SPECIFIC ANTIGEN (PSA) LEVEL., Int. J. of Adv. Res., 7 (03), 549-553, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/8669

Corresponding Author

Dr Vijay kumar
Assistant Professor, Department of Pathology, LLRM Medical College, Meerut
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.